ArticleAddiction science & clinical practice2026
24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart review.
Pouya Azar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.